Human papillomavirus vaccinations matter!
Menée en Australie auprès de 400 hommes homosexuels, cette étude analyse la prévalence des infections par le papillomavirus humain (HPV) avant et après la mise en
In the 20th century, a range of vaccines enabled major medical breakthroughs that helped to prevent disease, protect public health, and reduce inequities in health care. Crucially, once these vaccines had been proven safe and effective, health gains relied on timely delivery and high uptake. Eric Chow and colleagues report in The Lancet Infectious Diseases about the efficacy of male human papillomavirus (HPV) vaccination against the prevalence of high-risk HPV infections in young men who have sex with men (MSM). This cross-sectional study, which took place in an urban Australian setting where the uptake of the HPV vaccine is high, showed a substantial reduction in the prevalence of anal HPV16 infection in those who had been vaccinated compared with those who had not.